Insuline glargine (Lantus®), behandeling diabetes mellitus


1. Pieber TR, et al. Diabetes Care 2000; 23: 157-162.
2. Rosenstock J, et al. Diabetes Care 2000; 23: 1137-1142.
3. Ratner RE, et al. Diabetes Care 2000; 23: 639-643.
4. Raskin P, et al. Diabetes Care 2000; 23: 1666-1671.
5. Yki-Järvinen H, et al. Diabetes Care 2000; 23: 1130-1136.
6. Rosenstock J, et al. Diabetes Care 2001; 24: 631-636.
7. Schober E, et al. J Pediatr Endocrin Met 2002; 15: 369-376.
8. Productinformatie insuline glargine (Lantus®) via: www. emea.eu. int, human medicines, EPARs.
9. www.fda.gov/cder/foi/appletter/2000/2108lltr.pdf.    

Auteurs

  • dr D. Bijl